Ackerman ME - Search Results

1

Engineering broadly neutralizing antibodies for HIV prevention and therapy.

Hua CK, Ackerman ME. Hua CK, et al. Among authors: ackerman me. Adv Drug Deliv Rev. 2016 Aug 1;103:157-173. doi: 10.1016/j.addr.2016.01.013. Epub 2016 Jan 29. Adv Drug Deliv Rev. 2016. PMID: 26827912 Free PMC article. Review.

2

Enhanced phagocytic activity of HIV-specific antibodies correlates with natural production of immunoglobulins with skewed affinity for FcγR2a and FcγR2b.

Ackerman ME, Dugast AS, McAndrew EG, Tsoukas S, Licht AF, Irvine DJ, Alter G. Ackerman ME, et al. J Virol. 2013 May;87(10):5468-76. doi: 10.1128/JVI.03403-12. Epub 2013 Mar 6. J Virol. 2013. PMID: 23468489 Free PMC article.

3

Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity.

Ackerman ME, Crispin M, Yu X, Baruah K, Boesch AW, Harvey DJ, Dugast AS, Heizen EL, Ercan A, Choi I, Streeck H, Nigrovic PA, Bailey-Kellogg C, Scanlan C, Alter G. Ackerman ME, et al. J Clin Invest. 2013 May;123(5):2183-92. doi: 10.1172/JCI65708. Epub 2013 Apr 8. J Clin Invest. 2013. PMID: 23563315 Free PMC article.

4

Mapping the journey to an HIV vaccine.

Ackerman M, Alter G. Ackerman M, et al. N Engl J Med. 2013 Jul 25;369(4):389-91. doi: 10.1056/NEJMcibr1304437. N Engl J Med. 2013. PMID: 23883384 Free article. No abstract available.

5

Divergent antibody subclass and specificity profiles but not protective HLA-B alleles are associated with variable antibody effector function among HIV-1 controllers.

Lai JI, Licht AF, Dugast AS, Suscovich T, Choi I, Bailey-Kellogg C, Alter G, Ackerman ME. Lai JI, et al. Among authors: ackerman me. J Virol. 2014 Mar;88(5):2799-809. doi: 10.1128/JVI.03130-13. Epub 2013 Dec 18. J Virol. 2014. PMID: 24352471 Free PMC article.

6

Directed evolution of a yeast-displayed HIV-1 SOSIP gp140 spike protein toward improved expression and affinity for conformational antibodies.

Grimm SK, Battles MB, Ackerman ME. Grimm SK, et al. Among authors: ackerman me. PLoS One. 2015 Feb 17;10(2):e0117227. doi: 10.1371/journal.pone.0117227. eCollection 2015. PLoS One. 2015. PMID: 25688555 Free PMC article.

7

Prospects for engineering HIV-specific antibodies for enhanced effector function and half-life.

Boesch AW, Alter G, Ackerman ME. Boesch AW, et al. Among authors: ackerman me. Curr Opin HIV AIDS. 2015 May;10(3):160-9. doi: 10.1097/COH.0000000000000149. Curr Opin HIV AIDS. 2015. PMID: 25700208 Free PMC article. Review.

8

Antibody humanization by structure-based computational protein design.

Choi Y, Hua C, Sentman CL, Ackerman ME, Bailey-Kellogg C. Choi Y, et al. Among authors: ackerman me. MAbs. 2015;7(6):1045-57. doi: 10.1080/19420862.2015.1076600. Epub 2015 Aug 7. MAbs. 2015. PMID: 26252731 Free PMC article.

9

λ Light Chain Bias Associated With Enhanced Binding and Function of Anti-HIV Env Glycoprotein Antibodies.

Sajadi MM, Farshidpour M, Brown EP, Ouyang X, Seaman MS, Pazgier M, Ackerman ME, Robinson H, Tomaras G, Parsons MS, Charurat M, DeVico AL, Redfield RR, Lewis GK. Sajadi MM, et al. Among authors: ackerman me. J Infect Dis. 2016 Jan 1;213(1):156-64. doi: 10.1093/infdis/jiv448. Epub 2015 Sep 7. J Infect Dis. 2016. PMID: 26347575 Free PMC article.

10

The role of Fc receptors in HIV prevention and therapy.

Boesch AW, Brown EP, Ackerman ME. Boesch AW, et al. Among authors: ackerman me. Immunol Rev. 2015 Nov;268(1):296-310. doi: 10.1111/imr.12339. Immunol Rev. 2015. PMID: 26497529 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters